⌘K

Home/Filings/4/0001493152-19-000674

4//SEC Filing

GLECKEL LOUIS MD 4

Accession 0001493152-19-000674

CIK 0000868278other

View on SEC.gov Company Profile

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 7:40 PM ET

Size

4.8 KB

Accession

0001493152-19-000674

Insider Transaction Report

Form 4

Period: 2019-01-02

ProPhase Labs, Inc.PRPH

GLECKEL LOUIS MD

10% Owner

Transactions

Award
Common Stock, par value $0.0005
2019-01-02$3.14/sh+3,583$11,251→ 90,292 total

Footnotes (1)

[F1]These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1

filerCIK 0001164762

Filing Metadata

Form type: 4
Filed: Jan 14, 7:00 PM ET
Accepted: Jan 15, 7:40 PM ET
Size: 4.8 KB

View on SEC.gov